AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
DHEA AND THE INTRACRINE FORMATION OF ANDROGENS AND ESTROGENS IN PERIPHERAL TARGET TISSUES - ITS ROLE DURING AGING
Authors: LABRIE F BELANGER A LUUTHE V LABRIE C SIMARD J CUSAN L GOMEZ JL CANDAS B
Citation: F. Labrie et al., DHEA AND THE INTRACRINE FORMATION OF ANDROGENS AND ESTROGENS IN PERIPHERAL TARGET TISSUES - ITS ROLE DURING AGING, Steroids, 63(5-6), 1998, pp. 322-328
BENEFICIAL EFFECT OF COMBINATION HORMONAL-THERAPY ADMINISTERED PRIOR AND FOLLOWING EXTERNAL-BEAM RADIATION-THERAPY IN LOCALIZED PROSTATE-CANCER
Authors: LAVERDIERE J GOMEZ JL CUSAN L SUBURU ER DIAMOND P LEMAY M CANDAS B FORTIN A LABRIE F
Citation: J. Laverdiere et al., BENEFICIAL EFFECT OF COMBINATION HORMONAL-THERAPY ADMINISTERED PRIOR AND FOLLOWING EXTERNAL-BEAM RADIATION-THERAPY IN LOCALIZED PROSTATE-CANCER, International journal of radiation oncology, biology, physics, 37(2), 1997, pp. 247-252
NEOADJUVANT HORMONAL-THERAPY - THE CANADIAN EXPERIENCE
Authors: LABRIE F CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M TETU B FRADET Y BELANGER A CANDAS B
Citation: F. Labrie et al., NEOADJUVANT HORMONAL-THERAPY - THE CANADIAN EXPERIENCE, Urology, 49(3A), 1997, pp. 56-64
DIAGNOSIS OF ADVANCED OR NONCURABLE PROSTATE-CANCER CAN BE PRACTICALLY ELIMINATED BY PROSTATE-SPECIFIC ANTIGEN - REPLY
Authors: LABRIE F CANDAS B CUSAN L GOMEZ JL DIAMOND P LEMAY M
Citation: F. Labrie et al., DIAGNOSIS OF ADVANCED OR NONCURABLE PROSTATE-CANCER CAN BE PRACTICALLY ELIMINATED BY PROSTATE-SPECIFIC ANTIGEN - REPLY, Urology, 49(2), 1997, pp. 307-307
MARKED DECLINE IN SERUM CONCENTRATIONS OF ADRENAL C19 SEX STEROID PRECURSORS AND CONJUGATED ANDROGEN METABOLITES DURING AGING
Authors: LABRIE F BELANGER A CUSAN L GOMEZ JL CANDAS B
Citation: F. Labrie et al., MARKED DECLINE IN SERUM CONCENTRATIONS OF ADRENAL C19 SEX STEROID PRECURSORS AND CONJUGATED ANDROGEN METABOLITES DURING AGING, The Journal of clinical endocrinology and metabolism, 82(8), 1997, pp. 2396-2402
PHYSIOLOGICAL-CHANGES IN DEHYDROEPIANDROSTERONE ARE NOT REFLECTED BY SERUM LEVELS OF ACTIVE ANDROGENS AND ESTROGENS BUT OF THEIR METABOLITES - INTRACRINOLOGY
Authors: LABRIE F BELANGER A CUSAN L CANDAS B
Citation: F. Labrie et al., PHYSIOLOGICAL-CHANGES IN DEHYDROEPIANDROSTERONE ARE NOT REFLECTED BY SERUM LEVELS OF ACTIVE ANDROGENS AND ESTROGENS BUT OF THEIR METABOLITES - INTRACRINOLOGY, The Journal of clinical endocrinology and metabolism, 82(8), 1997, pp. 2403-2409
EFFECT OF 12-MONTH DEHYDROEPIANDROSTERONE REPLACEMENT THERAPY ON BONE, VAGINA, AND ENDOMETRIUM IN POSTMENOPAUSAL WOMEN
Authors: LABRIE F DIAMOND P CUSAN L GOMEZ JL BELANGER A CANDAS B
Citation: F. Labrie et al., EFFECT OF 12-MONTH DEHYDROEPIANDROSTERONE REPLACEMENT THERAPY ON BONE, VAGINA, AND ENDOMETRIUM IN POSTMENOPAUSAL WOMEN, The Journal of clinical endocrinology and metabolism, 82(10), 1997, pp. 3498-3505
HISTORY OF LHRH AGONIST AND COMBINATION THERAPY IN PROSTATE-CANCER
Authors: LABRIE F BELANGER A CUSAN L LABRIE C SIMARD J LUUTHE V DIAMOND P GOMEZ JL CANDAS B
Citation: F. Labrie et al., HISTORY OF LHRH AGONIST AND COMBINATION THERAPY IN PROSTATE-CANCER, Endocrine-related cancer, 3(3), 1996, pp. 243-278
ANDROGEN RECEPTOR MODULATION IN BENIGN HUMAN PROSTATIC TISSUE AND PROSTATIC ADENOCARCINOMA DURING NEOADJUVANT ENDOCRINE COMBINATION THERAPY
Authors: VANDERKWAST TH TETU B FRADET Y DUPONT A GOMEZ J CUSAN L DIAMOND P LABRIE F
Citation: Th. Vanderkwast et al., ANDROGEN RECEPTOR MODULATION IN BENIGN HUMAN PROSTATIC TISSUE AND PROSTATIC ADENOCARCINOMA DURING NEOADJUVANT ENDOCRINE COMBINATION THERAPY, The Prostate, 28(4), 1996, pp. 227-231
EFFECT OF NEOADJUVANT ENDOCRINE THERAPY (COMBINED ANDROGEN BLOCKADE) ON NORMAL PROSTATE AND PROSTATIC-CARCINOMA - A RANDOMIZED STUDY
Authors: VAILLANCOURT L TETU B FRADET Y DUPONT A GOMEZ J CUSAN L SUBURU ER DIAMOND P CANDAS B LABRIE F
Citation: L. Vaillancourt et al., EFFECT OF NEOADJUVANT ENDOCRINE THERAPY (COMBINED ANDROGEN BLOCKADE) ON NORMAL PROSTATE AND PROSTATIC-CARCINOMA - A RANDOMIZED STUDY, The American journal of surgical pathology, 20(1), 1996, pp. 86-93
DIAGNOSIS OF ADVANCED OR NONCURABLE PROSTATE-CANCER CAN BE PRACTICALLY ELIMINATED BY PROSTATE-SPECIFIC ANTIGEN
Authors: LABRIE F CANDAS B CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M
Citation: F. Labrie et al., DIAGNOSIS OF ADVANCED OR NONCURABLE PROSTATE-CANCER CAN BE PRACTICALLY ELIMINATED BY PROSTATE-SPECIFIC ANTIGEN, Urology, 47(2), 1996, pp. 212-217
METABOLIC EFFECTS OF 12-MONTH PERCUTANEOUS DEHYDROEPIANDROSTERONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN
Authors: DIAMOND P CUSAN L GOMEZ JL BELANGER A LABRIE F
Citation: P. Diamond et al., METABOLIC EFFECTS OF 12-MONTH PERCUTANEOUS DEHYDROEPIANDROSTERONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN, Journal of Endocrinology, 150, 1996, pp. 43-50
THE IMPACT OF FAMILY HISTORY ON EARLY DETECTION OF PROSTATE-CANCER
Authors: NAROD SA DUPONT A CUSAN L DIAMOND P GOMEZ JL SUBURU R LABRIE F
Citation: Sa. Narod et al., THE IMPACT OF FAMILY HISTORY ON EARLY DETECTION OF PROSTATE-CANCER, Nature medicine, 1(2), 1995, pp. 99-101
DOWNSTAGING BY COMBINATION THERAPY WITH FLUTAMIDE AND AN LHRH AGONISTBEFORE RADICAL PROSTATECTOMY
Authors: LABRIE F CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M TETU B FRADET Y CANDAS B
Citation: F. Labrie et al., DOWNSTAGING BY COMBINATION THERAPY WITH FLUTAMIDE AND AN LHRH AGONISTBEFORE RADICAL PROSTATECTOMY, Cancer surveys, 23, 1995, pp. 149-156
COMBINATION OF SCREENING AND PREOPERATIVE ENDOCRINE THERAPY - THE POTENTIAL FOR AN IMPORTANT DECREASE IN PROSTATE-CANCER MORTALITY
Authors: LABRIE F CUSAN L GOMEZ JL DIAMOND P CANDAS B
Citation: F. Labrie et al., COMBINATION OF SCREENING AND PREOPERATIVE ENDOCRINE THERAPY - THE POTENTIAL FOR AN IMPORTANT DECREASE IN PROSTATE-CANCER MORTALITY, The Journal of clinical endocrinology and metabolism, 80(7), 1995, pp. 2002-2013
METASTATIC PROSTATE-CANCER PULMONARY NODULES - BENEFICIAL-EFFECTS OF COMBINATION THERAPY AND SUBSEQUENT WITHDRAWAL OF FLUTAMIDE
Authors: CUSAN L GOMEZ JL DUPONT A DIAMOND P LEMAY M MOORE S LABRIE F
Citation: L. Cusan et al., METASTATIC PROSTATE-CANCER PULMONARY NODULES - BENEFICIAL-EFFECTS OF COMBINATION THERAPY AND SUBSEQUENT WITHDRAWAL OF FLUTAMIDE, The Prostate, 24(5), 1994, pp. 257-261
STRATIFICATION OF STAGE D2 PROSTATE-CANCER PATIENTS BY A DISEASE AGGRESSIVENESS SCORE AND ITS USE IN EVALUATING DISEASE RESPONSE AND OUTCOME TO COMBINATION HORMONAL TREATMENT (GNRH-A PLUS FLUTAMIDE)
Authors: KOUTSILIERIS M DUPONT A GOMEZ J CUSAN L SUBURU R DIAMOND P LABRIE F
Citation: M. Koutsilieris et al., STRATIFICATION OF STAGE D2 PROSTATE-CANCER PATIENTS BY A DISEASE AGGRESSIVENESS SCORE AND ITS USE IN EVALUATING DISEASE RESPONSE AND OUTCOME TO COMBINATION HORMONAL TREATMENT (GNRH-A PLUS FLUTAMIDE), Anticancer research, 14(2B), 1994, pp. 627-634
DOWN-STAGING OF EARLY-STAGE PROSTATE-CANCER BEFORE RADICAL PROSTATECTOMY - THE FIRST RANDOMIZED TRIAL OF NEOADJUVANT COMBINATION THERAPY WITH FLUTAMIDE AND A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST
Authors: LABRIE F CUSAN L GOMEZ JL DIAMOND P SUBURU R LEMAY M TETU B FRADET Y CANDAS B
Citation: F. Labrie et al., DOWN-STAGING OF EARLY-STAGE PROSTATE-CANCER BEFORE RADICAL PROSTATECTOMY - THE FIRST RANDOMIZED TRIAL OF NEOADJUVANT COMBINATION THERAPY WITH FLUTAMIDE AND A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST, Urology, 44(6A), 1994, pp. 29-37
ANDROGEN RECEPTORS IN NORMAL PROSTATE AND PROSTATIC-CARCINOMA FOLLOWING NEOADJUVANT HORMONE-THERAPY (TOTAL ANDROGEN BLOCKADE)
Authors: TETU B VANDERKWAST T FRADET Y DUPONT A GOMEZ J CUSAN L DIAMOND P LABRIE F
Citation: B. Tetu et al., ANDROGEN RECEPTORS IN NORMAL PROSTATE AND PROSTATIC-CARCINOMA FOLLOWING NEOADJUVANT HORMONE-THERAPY (TOTAL ANDROGEN BLOCKADE), Laboratory investigation, 70(1), 1994, pp. 10000084-10000084
EFFECT OF NEOADJUVANT ENDOCRINE THERAPY (TOTAL ANDROGEN BLOCKADE) ON NORMAL PROSTATE AND PROSTATIC-CARCINOMA - A RANDOMIZED STUDY
Authors: VAILLANCOURT L TETU B FRADET Y DUPONT A GOMEZ J CUSAN L DIAMOND P LABRIE F
Citation: L. Vaillancourt et al., EFFECT OF NEOADJUVANT ENDOCRINE THERAPY (TOTAL ANDROGEN BLOCKADE) ON NORMAL PROSTATE AND PROSTATIC-CARCINOMA - A RANDOMIZED STUDY, Laboratory investigation, 70(1), 1994, pp. 10000085-10000085
CHANGES IN SERUM CONCENTRATIONS OF CONJUGATED AND UNCONJUGATED STEROIDS IN 40-YEAR-OLD TO 80-YEAR-OLD MEN
Authors: BELANGER A CANDAS B DUPONT A CUSAN L DIAMOND P GOMEZ JL LABRIE F
Citation: A. Belanger et al., CHANGES IN SERUM CONCENTRATIONS OF CONJUGATED AND UNCONJUGATED STEROIDS IN 40-YEAR-OLD TO 80-YEAR-OLD MEN, The Journal of clinical endocrinology and metabolism, 79(4), 1994, pp. 1086-1090
CHANGES IN SERUM CONCENTRATIONS OF CONJUGATED AND UNCONJUGATED STEROIDS IN 40-YEAR-OLD TO 80-YEAR-OLD MEN
Authors: BELANGER A CANDAS B DUPONT A CUSAN L DIAMOND P GOMEZ JL LABRIE F
Citation: A. Belanger et al., CHANGES IN SERUM CONCENTRATIONS OF CONJUGATED AND UNCONJUGATED STEROIDS IN 40-YEAR-OLD TO 80-YEAR-OLD MEN, The Journal of clinical endocrinology and metabolism, 79(4), 1994, pp. 1086-1090
COMPARISON OF FLUTAMIDE AND SPIRONOLACTONE IN THE TREATMENT OF HIRSUTISM - A RANDOMIZED CONTROLLED TRIAL
Authors: CUSAN L DUPONT A GOMEZ JL TREMBLAY RR LABRIE F
Citation: L. Cusan et al., COMPARISON OF FLUTAMIDE AND SPIRONOLACTONE IN THE TREATMENT OF HIRSUTISM - A RANDOMIZED CONTROLLED TRIAL, Fertility and sterility, 61(2), 1994, pp. 281-287
OPTIMIZED STRATEGY FOR DETECTION OF EARLY-STAGE, CURABLE PROSTATE-CANCER - ROLE OF PRESCREENING WITH PROSTATE-SPECIFIC ANTIGEN
Authors: LABRIE F DUPONT A SUBURU R CUSAN L GOMEZ JL KOUTSILIERIS M DIAMOND P EMOND J LEMAY M CANDAS B
Citation: F. Labrie et al., OPTIMIZED STRATEGY FOR DETECTION OF EARLY-STAGE, CURABLE PROSTATE-CANCER - ROLE OF PRESCREENING WITH PROSTATE-SPECIFIC ANTIGEN, Clinical and investigative medicine, 16(6), 1993, pp. 425-439
DOWNSTAGING OF LOCALIZED PROSTATE-CANCER BY NEOADJUVANT THERAPY WITH FLUTAMIDE AND LUPRON - THE FIRST CONTROLLED AND RANDOMIZED TRIAL
Authors: LABRIE F DUPONT A CUSAN L GOMEZ J DIAMOND P KOUTSILIERIS M SUBURU R FRADET Y LEMAY M TETU B EMOND J CANDAS B
Citation: F. Labrie et al., DOWNSTAGING OF LOCALIZED PROSTATE-CANCER BY NEOADJUVANT THERAPY WITH FLUTAMIDE AND LUPRON - THE FIRST CONTROLLED AND RANDOMIZED TRIAL, Clinical and investigative medicine, 16(6), 1993, pp. 499-509
Risultati: 1-25 | 26-28